Fifth Annual bioMérieux Antimicrobial Resistance Symposium Brings Public Health Leaders Together in Toronto

Tuesday at 5:20pm AST · November 17, 2026 3 min read

TORONTO, Nov. 17, 2026 /CNW/ — The 5th Annual Antimicrobial Resistance (AMR) Symposium, hosted by bioMérieux Canada, will bring together government representatives, public health leaders, clinicians, researchers and laboratory experts on November 19, 2026. Participants will take stock of five years of progress against AMR in Canada and discuss priorities for the years ahead, under the theme “Fighting AMR: Where We Can Make the Most Impact.”

The 5th Annual AMR Symposium is a gathering of the clinical, public health and policy dimensions of antimicrobial resistance. The program includes sessions on rapid diagnostics and sepsis, surveillance and data, antimicrobial stewardship and national coordination, as well as a closing panel hosted by the Canadian Breakpoint Podcast.

Confirmed speakers and participants include:

  • Dr Joss Reimer, Chief Public Health Officer of Canada
  • Michael Sherar, President and CEO, Public Health Ontario
  • Jessica Blavignac, Director of Scientific and Medical Affairs, bioMérieux, Canada
  • Dr Herman Barkema, Director, CAN AMR Net and AMR One Health Consortium
  • Dr Natasha Christie-Holmes, Director, EPIC / University of Toronto
  • Dr David Goldfarb, President, Canadian Foundation for Infectious Diseases
  • Dr Marek Smieja, Vice President, Canadian Foundation for Infectious Diseases
  • Dr Dao Nugyen, Director, McGill AMR Centre (by phone)

When

  • Wednesday, November 18, 2026 at 6:00 p.m.: Welcome reception with opening remarks
  • Thursday, November 19, 2026 at 8:30 a.m. : Conference Day starts with remarks by Canada’s Chief Public Health Officer, Dr. Joss Reimer at 8:45 a.m.

Where

Hyatt Regency Toronto, 370 King St W, Toronto ON M5V 1J9

Additional speakers include representatives of the Public Health Agency of Canada, AMMI Canada, Sepsis Canada, CAN-AMR-Net and the Canadian Infectious Disease Foundation.

For more information about the Symposium, visit: https://www.amrsymposium.com/program

Why it matters

Antimicrobial resistance is one of the most serious threats to health systems in Canada and worldwide. It lengthens hospital stays, strains laboratory and hospital capacity, and carries a measurable economic cost. The Symposium brings together the people who shape the response across governments, institutions and the clinical community.

Media access

Journalists are invited to attend the opening reception and the November 19 program. Please register in advance with the media contact below by November 18, 5 p.m. Interview opportunities with speakers will be confirmed on site, subject to availability. A dedicated media space will be available on November 19 at noon. Photo and video capture is permitted in common areas; please check with the media contact before recording sessions.

About bioMérieux

bioMérieux is a family-owned global leader in in vitro diagnostics, with a focus on infectious diseases. Its solutions support the detection of infections, the management of sepsis and the appropriate use of antimicrobials. Founded in 1963 and present in Canada for more than 30 years, bioMérieux Canada is headquartered in Saint-Laurent, Quebec. bioMérieux has hosted the annual AMR Symposium in Canada since 2022, bringing together clinicians, researchers, public health leaders and government representatives.

SOURCE bioMérieux

displaying rededs